OF THE
TIMES
The best-known financial firms holding the stock of war corporations include: Vanguard Group, BlackRock, State Street, JPMorgan Chase, Wells Fargo, and Wellington Management.
"We should start to think about it as a flu jab, as something elderly or vulnerable people make sure they have every year.Fox News reports that Johnson & Johnson's vaccine is pending emergency authorisation by the FDA - this means that its not proven to be safe to use - and they're also claiming that these vaccines will become like annual flu jabs:
"I have no doubt that the vaccines will get better and better at being able to cover for all variants."
He had earlier told MPs at Prime Minister's Questions: "We, I think we're going to have to get used to the idea of vaccinating and then revaccinated in the autumn, as we as we come to face these new variants."
At the weekend scientists and ministers warned a boost jab might be needed for people later this year to tackle the new variants which are spreading across the world.
The vaccines so far do have an affect on the new strains, according to early research, but some mild illness is still occurring in some studies.
And worse: At least twenty-three people die in Norway within days of receiving Pfizer coronavirus vaccine
In order to combat that, scientists are looking at tweaking their vaccines, ready for boosters later in the year if needed.
It comes after The Sun revealed last night just one Covid jab offers two-thirds protection against the virus, the first official data from the vaccine blitz reveals.
Findings — due out in days — will show the Pfizer vaccine starts to work in as little as two weeks and is equally effective in OAPs as younger adults.
The Oxford/AstraZeneca jab offers similar protection.
Europe has banned AstraZeneca's for OAPs and the vulnerable - what they claimed to be the target audience - because of safety concerns.
The good news — as Sir Michael Caine backed the jabs drive and the number vaccinated rose to 12.65million — raises hopes of an earlier exit from lockdown.
This contradicts the claims above that all need to be vaccinated before lockdown will be lifted.
The dose reduced the symptomatic infection risk by 65 per cent in younger adults, and 64 per cent in over-80s.
Experts found Brits given two shots of the jab saw protection rise to between 79 and 84 per cent, depending on age.
Russia's Sputnik V is 91% effective after one dose and this has been confirmed by independent testing.
Although lower than the 95 per cent efficacy shown in clinical trials, the figures remain hugely encouraging.
Early data suggests hospital cases among immunised older Brits have started falling to a "fraction of previous levels".
A Government source said: "One of the key findings is the Pfizer vaccine is having just as big an impact in over-80s as in under-65s.
"The only difference is that protection starts after 15 days in younger age groups, but it takes three weeks for it to work in older people."
Paul Hunter, professor of medicine at the University of East Anglia, said the data was "quite amazing".
He told The Sun: "If these numbers are borne out, then they are very reassuring.
"If they are achieving 65 per cent protection after three weeks with both jabs, then I think that's really good.
"And that's a vindication of our current strategy as it protects more people than giving two doses three weeks apart.
"I am still, despite the South African strain, quite confident that we will see a gradual opening of the society, probably starting with schools opening early March."
"Unfortunately, as [the virus] spreads, it can also mutate," Alex Gorsky, Johnson & Johnson CEO recently told CNBC. "Every time it mutates, it's almost like another click of the dial so to speak where we can see another variant, another mutation that can have an impact on its ability to fend off antibodies or to have a different kind of response not only to a therapeutic but also to a vaccine."For more on these experimental vaccines, see:
Johnson & Johnson's vaccine, which is pending FDA emergency use authorization, is a one-dose jab that was developing using an adenovirus rather than mRNA technology relied on by Moderna and Pfizer. Interestingly, Johnson & Johnson's vaccine showed 66% efficacy in a global trial, whereas the other two showed around 94% to 95% efficacy against the virus.
The company also has a two-dose vaccine in the works, but trial data is not expected until later this year, Gorsky told CNBC.
Both Moderna and Pfizer have vouched for their vaccines' ability to fend off coronavirus variants, though Dr. Anthony Fauci has said the South African variant may prove troublesome as has shown to have "clinical consequences."
Fauci said the variants should serve as a "wake-up call" to governments and companies currently developing vaccines that it is essential to "be nimble to be able to readily adjust, readily make versions of the vaccine that actually are specifically directed toward whatever mutation is actually prevalent at any given time."
That said, Pfizer has previously touted its mRNA technology's "flexibility," which could easily allow for tweaks to the product should the need arise.
Former President Donald Trump is reportedly "furious" with the way that his impeachment defense team performed on day one of his Senate trial.
"Two sources in fact, who spent time with the former president today described him as being quote, 'furious and beyond angry' with his impeachment defense team," Fox News correspondent Kevin Corke reported. "He was especially upset with attorney Bruce Castor, as you pointed out for his quotes, 'rambling opening argument'. The former president spending the day watching the trial from inside his private quarters at Mar-A-Lago, no golf with the very same plan for tomorrow."
"Meanwhile, at a time when he certainly could opt to reduce the political temperature in the country, Mr. Biden apparently is taking a pass, opting instead to not weigh in as his predecessors being impeached once again, despite what critics have called hypocrisy on the left, and a deafening silence from the White House," Corke added.
Trump's impeachment defense team underwent some issues recently with numerous high-profile lawyers parting ways with the team just days before the Senate trial started this week. The Daily Wire reported at the end of last month:Multiple reports indicated that Butch Bowers, a South Carolina lawyer who assembled the impeachment defense team, and Deborah Barbier, a criminal defense lawyer in South Carolina, were no longer going to be part of Trump's team and that the decision was "mutual." Josh Howard, a North Carolina attorney, has also reportedly left Trump's team, and South Carolina lawyers Johnny Gasser and Greg Harris are also reportedly out. ...
CNN, The New York Times, and The Associated Press noted that the team fell apart after Trump wanted them to focus on claims that the election was stolen from through election fraud — a claim that former Attorney General William Barr, a favorite in Trump world, had completely dismissed as false. The lawyers reportedly said no, and that was when the parties decided to part ways.
Comment: What has France got to hide?